Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
This decision should be made by your prescriber based on your individual clinical picture
The compound exists in a regulatory gray area that differs somewhat from the United States market
It lowers blood sugar, increasing the risk of low blood sugar (hypoglycemia) when used with insulin or similar medications
Here, the evidence raises a separate caution: a 2024 review discussing GLP1 receptor agonists and implantation stresses uncertainty about how these drugs may affect endometrial receptivity , and a PCOS-focused review reiterates that GLP1RAs are not advised during pregnancy (while also noting limited human exposure data)
Rare but serious risks include pancreatitis, gallbladder disease, acute kidney injury (secondary to dehydration from GI effects), and a theoretical thyroid C-cell tumor risk based on rodent data that has not been confirmed in human post-marketing surveillance
Evaluation of -amino acid replacements in protein loops: effects on conformational stability and structure
